Piper Sandler raised the firm’s price target on GE HealthCare to $94 from $84 and keeps an Overweight rating on the shares. The firm notes the company reported Q4 results, with revenue and EPS finishing above consensus as three of the four segments contributed to strong top-line results and gross margin percentage moved nicely higher, while orders also grew better than most expected at +3% year-over-year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on GEHC: